Switch to:
More From Other Websites
ARIAD Announces Webcast of Its Annual Stockholders Meeting Jun 24 2016
Five companies that could buy Ariad this year for as much as $2.9B Jun 23 2016
ARIAD Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ARIA) : June 21, 2016 Jun 21 2016
ARIAD Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARIA-US : June... Jun 20 2016
ARIAD Completes Strategic Review and Announces Plans for Growth Jun 17 2016
Why Mosaic, Vale, and Three Other Stocks Are in the Spotlight Jun 17 2016
ARIAD Initiates Submission Of NDA For Brigatinib Ahead Of Plan Jun 17 2016
ARIAD Announces Distribution Agreements for Iclusig® in Latin America and the Middle East/North... Jun 17 2016
ARIAD Initiates Submission of New Drug Application for Brigatinib to the U.S. Food and Drug... Jun 17 2016
ARIAD (ARIA) Presents Long-Term Phase II Data on Iclusig Jun 14 2016
Ariad Reveals Ponatinib's Long-Term Safety And Efficacy Data From Stage 2 Clinical Study Jun 13 2016
ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial Jun 13 2016
Ariad Pharmaceuticals, Inc. (ARIA) To Seek Regulatory Clearance For Brigatinib In 3Q Jun 08 2016
What Helped Incyte Report Growth in 1Q16? Jun 08 2016
Research Coverage Scans Stocks on the Biotechnology Industry for Today Jun 08 2016
ARIAD to Host Analyst & Investor Day in New York City Jun 08 2016
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 07 2016
ARIAD (ARIA) Presents Phase II Study Data on Cancer Drug Jun 07 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK